Citadel Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.09M | Sell |
502,800
-350,200
| -41% | -$3.17M | ﹤0.01% | 4675 |
|
|
2025
Q4 | $5.73M | Sell |
853,000
-286,800
| -25% | -$2.16M | ﹤0.01% | 4077 |
|
|
2025
Q3 | $9.88M | Sell |
1,139,800
-102,700
| -8% | -$799K | ﹤0.01% | 3292 |
|
|
2025
Q2 | $7.83M | Buy |
1,242,500
+592,000
| +91% | +$3.92M | ﹤0.01% | 3383 |
|
|
2025
Q1 | $4.17M | Sell |
650,500
-414,400
| -39% | -$3.43M | ﹤0.01% | 4188 |
|
|
2024
Q4 | $8.56M | Sell |
1,064,900
-138,200
| -11% | -$1.33M | ﹤0.01% | 3187 |
|
|
2024
Q3 | $15.2M | Sell |
1,203,100
-208,500
| -15% | -$2.69M | ﹤0.01% | 2361 |
|
|
2024
Q2 | $17.9M | Buy |
1,411,600
+643,300
| +84% | +$6.47M | ﹤0.01% | 2111 |
|
|
2024
Q1 | $3.67M | Buy |
768,300
+198,800
| +35% | +$922K | ﹤0.01% | 4463 |
|
|
2023
Q4 | $2.73M | Sell |
569,500
-137,700
| -19% | -$843K | ﹤0.01% | 4815 |
|
|
2023
Q3 | $5.12M | Buy |
707,200
+211,600
| +43% | +$1.69M | ﹤0.01% | 3609 |
|
|
2023
Q2 | $3.68M | Sell |
495,600
-190,200
| -28% | -$1.5M | ﹤0.01% | 4118 |
|
|
2023
Q1 | $4.75M | Sell |
685,800
-408,800
| -37% | -$3.76M | ﹤0.01% | 3908 |
|
|
2022
Q4 | $11.3M | Buy |
1,094,600
+548,700
| +101% | +$9.68M | ﹤0.01% | 2661 |
|
|
2022
Q3 | $9.94M | Sell |
545,900
-909,000
| -62% | -$39.4M | ﹤0.01% | 2771 |
|
|
2022
Q2 | $74.8M | Buy |
1,454,900
+193,400
| +15% | +$10M | 0.02% | 752 |
|
|
2022
Q1 | $92.9M | Sell |
1,261,500
-280,500
| -18% | -$25M | 0.02% | 698 |
|
|
2021
Q4 | $221M | Buy |
1,542,000
+226,200
| +17% | +$38.9M | 0.05% | 311 |
|
|
2021
Q3 | $273M | Buy |
1,315,800
+185,200
| +16% | +$40.8M | 0.06% | 240 |
|
|
2021
Q2 | $240M | Buy |
1,130,600
+88,800
| +9% | +$16.3M | 0.05% | 260 |
|
|
2021
Q1 | $189M | Buy |
1,041,800
+146,200
| +16% | +$29.1M | 0.05% | 310 |
|
|
2020
Q4 | $99.9M | Sell |
895,600
-344,400
| -28% | -$36.6M | 0.03% | 555 |
|
|
2020
Q3 | $134M | Buy |
1,240,000
+936,900
| +309% | +$114M | 0.04% | 322 |
|
|
2020
Q2 | $25.3M | Buy |
303,100
+162,600
| +116% | +$6.22M | 0.01% | 1296 |
|
|
2020
Q1 | $1.91M | Buy |
140,500
+101,600
| +261% | +$860K | ﹤0.01% | 4215 |
|
|
2019
Q4 | $155K | Buy |
38,900
+23,700
| +156% | +$103K | ﹤0.01% | 8341 |
|
|
2019
Q3 | $76K | Buy |
+15,200
| New | +$83.2K | ﹤0.01% | 8592 |
|
|
2019
Q2 | – | Sell |
-24,745
| Closed | -$273K | – | 9642 |
|
|
2019
Q1 | $273K | Buy |
24,745
+11,985
| +94% | +$378K | ﹤0.01% | 7749 |
|
|
2018
Q4 | $470K | Sell |
12,760
-3,420
| -21% | -$133K | ﹤0.01% | 6491 |
|
|
2018
Q3 | $608K | Buy |
16,180
+4,680
| +41% | +$132K | ﹤0.01% | 6384 |
|
|
2018
Q2 | $308K | Buy |
11,500
+5,285
| +85% | +$179K | ﹤0.01% | 7165 |
|
|
2018
Q1 | $261K | Sell |
6,215
-1,285
| -17% | -$51.6K | ﹤0.01% | 6949 |
|
|
2017
Q4 | $186K | Buy |
7,500
+805
| +12% | +$19.6K | ﹤0.01% | 7160 |
|
|
2017
Q3 | $153K | Buy |
6,695
+320
| +5% | +$7.16K | ﹤0.01% | 6842 |
|
|
2017
Q2 | $147K | Buy |
6,375
+2,650
| +71% | +$52K | ﹤0.01% | 6757 |
|
|
2017
Q1 | $95K | Sell |
3,725
-1,585
| -30% | -$43.6K | ﹤0.01% | 6876 |
|
|
2016
Q4 | $134K | Sell |
5,310
-25,515
| -83% | -$744K | ﹤0.01% | 6559 |
|
|
2016
Q3 | $1.28M | Buy |
30,825
+22,630
| +276% | +$2.92M | ﹤0.01% | 3513 |
|
|
2016
Q2 | $1.19M | Buy |
8,195
+3,735
| +84% | +$428K | ﹤0.01% | 3359 |
|
|
2016
Q1 | $460K | Buy |
4,460
+605
| +16% | +$64.9K | ﹤0.01% | 4528 |
|
|
2015
Q4 | $647K | Sell |
3,855
-1,920
| -33% | -$295K | ﹤0.01% | 4135 |
|
|
2015
Q3 | $817K | Sell |
5,775
-160
| -3% | -$35.9K | ﹤0.01% | 4092 |
|
|
2015
Q2 | $1.32M | Buy |
5,935
+155
| +3% | +$27.2K | ﹤0.01% | 3601 |
|
|
2015
Q1 | $956K | Buy |
5,780
+2,640
| +84% | +$429K | ﹤0.01% | 3980 |
|
|
2014
Q4 | $372K | Buy |
3,140
+160
| +5% | +$16.7K | ﹤0.01% | 5127 |
|
|
2014
Q3 | $249K | Buy |
2,980
+1,145
| +62% | +$103K | ﹤0.01% | 5485 |
|
|
2014
Q2 | $170K | Sell |
1,835
-15
| -0.8% | -$1.32K | ﹤0.01% | 5732 |
|
|
2014
Q1 | $168K | Sell |
1,850
-40
| -2% | -$4.47K | ﹤0.01% | 5703 |
|
|
2013
Q4 | $194K | Buy |
1,890
+915
| +94% | +$64.6K | ﹤0.01% | 5055 |
|
|
2013
Q3 | $62K | Sell |
975
-290
| -23% | -$16.3K | ﹤0.01% | 5665 |
|
|
2013
Q2 | $52K | Buy |
+1,265
| New | +$54.8K | ﹤0.01% | 5643 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Citadel Advisors's NVAX Position: Q1 2026 in Review
Citadel Advisors increased its Novavax (NVAX) stake by 4.7% in Q1 2026, buying an estimated $453K and bringing the position to 1,123,746 shares worth $9.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3379.
Citadel Advisors first reported a position in NVAX in Q2 2013 and has held it in 49 quarters since. The position peaked at $145M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Citadel Advisors held 1,123,746 shares of Novavax worth $9.15M as of Q1 2026.
- Citadel Advisors bought 50,019 Novavax shares in Q1 2026, an estimated $453K.
- Novavax made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3379 holding.
- Citadel Advisors first reported a position in Novavax in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Novavax position peaked at $145M in Q2 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.